Lower Drug Costs for Families Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Lower Drug Costs for Families Act
This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance.
Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties.
The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 2554: Lower Drug Costs for Families Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-2554/
"H.R. 2554: Lower Drug Costs for Families Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-2554/.
H.R. 2554, 119th Cong. (2026), https://openamerica.io/bill/119-HR-2554/.
[H.R. 2554: Lower Drug Costs for Families Act](https://openamerica.io/bill/119-HR-2554/)